标题
The 29th Annual Prostate Cancer Foundation Scientific Retreat Report
作者
关键词
-
出版物
PROSTATE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-02
DOI
10.1002/pros.24640
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
- (2023) Anil P. Bidkar et al. CLINICAL CANCER RESEARCH
- Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
- (2023) Jamie M. Sperger et al. CLINICAL CANCER RESEARCH
- Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images
- (2023) Eric Erak et al. MODERN PATHOLOGY
- Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
- (2023) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer
- (2023) Thiago Vidotto et al. JCI Insight
- Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
- (2023) Martin K. Bakht et al. Nature Cancer
- Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations
- (2023) Samantha L. Schuster et al. Cell Reports
- A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
- (2023) Lisa A. King et al. Cancer Immunology Research
- The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells
- (2023) Daniela Brina et al. Nature Cancer
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
- (2022) Kathryn M. Tully et al. CLINICAL CANCER RESEARCH
- Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy
- (2022) Qing Cheng et al. EUROPEAN UROLOGY
- Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer.
- (2022) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor activity in T cells limits checkpoint blockade efficacy
- (2022) Xiangnan Guan et al. NATURE
- Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
- (2022) Saketh S. Dinavahi et al. Cancer Immunology Research
- Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Rahul Raj Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis
- (2022) Praful Ravi et al. JOURNAL OF UROLOGY
- Biological Aspects of Cancer Health Disparities
- (2021) Jennifer A. Freedman et al. Annual Review of Medicine
- Differential alternative RNA splicing and transcription events between tumors from African American and white patients in The Cancer Genome Atlas
- (2021) Muthana Al Abo et al. GENOMICS
- Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.
- (2021) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes Post Neoadjuvant Intense Hormone Therapy and Surgery for Patients with High-Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
- (2021) Rana R. McKay et al. JOURNAL OF UROLOGY
- Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
- (2021) Rebeca Lozano et al. EUROPEAN JOURNAL OF CANCER
- Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer
- (2021) Jacob E. Berchuck et al. EUROPEAN UROLOGY
- The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors
- (2021) Benoit Rousseau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
- (2021) W. Nathaniel Brennen et al. JCI Insight
- Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
- (2021) Jamie M. Sperger et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Christopher Sweeney et al. LANCET
- Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
- (2021) Ravi B. Patel et al. Science Translational Medicine
- Multiplexed functional genomic analysis of 5’ untranslated region mutations across the spectrum of prostate cancer
- (2021) Yiting Lim et al. Nature Communications
- Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
- (2021) Nicholas J. Brady et al. Nature Communications
- Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
- (2021) Ninghui Mao et al. Nature Communications
- Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation
- (2021) Alvaro Quintanal-Villalonga et al. Cancer Discovery
- Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity
- (2021) Ivana Grbesa et al. Cell Reports
- Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer
- (2021) Alok K. Tewari et al. Cell Reports
- Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
- (2021) Alvaro Quintanal-Villalonga et al. CANCER RESEARCH
- Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
- (2021) Joseph Sia et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
- (2020) Jiao Yuan et al. PLoS Genetics
- Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
- (2020) Michael D. Nyquist et al. Cell Reports
- Human γδ TCR Repertoires in Health and Disease
- (2020) Alina Suzann Fichtner et al. Cells
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
- (2020) Mesude Bicak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
- (2020) Sinan Wang et al. CLINICAL CANCER RESEARCH
- Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
- (2020) Sara A. Hurvitz et al. Nature Communications
- Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
- (2019) Rana R. McKay et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities
- (2019) Timothy J. Robinson et al. CLINICAL CANCER RESEARCH
- The Landscape of Circular RNA in Cancer
- (2019) Josh N. Vo et al. CELL
- Widespread and Functional RNA Circularization in Localized Prostate Cancer
- (2019) Sujun Chen et al. CELL
- CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis
- (2019) Michael A. Augello et al. CANCER CELL
- The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
- (2019) Yuzhen Liu et al. Science Translational Medicine
- Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small Cell Lung Cancer: Results From the Phase II TRINITY Study
- (2019) Daniel Morgensztern et al. CLINICAL CANCER RESEARCH
- The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
- (2019) Todd C. Knepper et al. CLINICAL CANCER RESEARCH
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
- (2018) Michael R. McDevitt et al. Nature Communications
- Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy
- (2017) Jeffrey J. Tosoian et al. EUROPEAN UROLOGY
- Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
- (2017) Ying-Chun Shen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
- (2017) Gabriel J. Starrett et al. mBio
- Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
- (2017) Bi-Dar Wang et al. Nature Communications
- Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations
- (2017) Franklin W. Huang et al. Cancer Discovery
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- Functional characterization of somatic mutations in cancer using network-based inference of protein activity
- (2016) Mariano J Alvarez et al. NATURE GENETICS
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
- (2014) F. Khani et al. CLINICAL CANCER RESEARCH
- Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer
- (2014) Zhiyong Liu et al. JOURNAL OF IMMUNOLOGY
- Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
- (2014) Diletta Di Mitri et al. NATURE
- Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy
- (2014) J. P. Weichert et al. Science Translational Medicine
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men
- (2013) I. J. Powell et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started